Cyclacel Pharmaceuticals Inc.
CYCCP | NASDAQ
$5.05
-$0.23 (-4.36%)
At close: Sep 11, 2025, 04:00 PM ET
Market Data
Market Cap $11.31M
Enterprise Value $7.52M
Beta 0.16
Average Volume N/A
Shares Outstanding (Diluted) 5.6M
Shares Change YoY 253.46%
Institutional Ownership N/A
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M N/A
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) 9.0%
1Y CAGR (ann.) -21.1%
5Y CAGR (ann.) 8.3%
All-Time CAGR 10.7%
Valuation
PE Ratio -1.39
Forward PE 0.01
PEG Ratio 0.02
Forward PEG 0.00
PS Ratio 6.08
Forward PS 0.10
PB Ratio 1.58
P/FCF Ratio -10.30
P/Adj. FCF Ratio -6.43
P/OCF Ratio -4.63
EV/Sales 4.04
EV/EBIT -2.75
EV/EBITDA -2.75
EV/FCF -6.85
Earnings Yield -72.1%
FCF Yield -9.7%
Adj. FCF Yield -15.6%
Financial Health
Net Cash $3.79M
Total Debt $0
Cash & Short-Term Investments $3.79M
Total Assets $7.85M
Current Ratio 7.06
Quick Ratio 5.87
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage -252,378.33
Altman Z-Score -71.51
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 19.3%
Operating Profit Margin -147.1%
EBITDA Margin 301.7%
Net Profit Margin -90302.0%
FCF Margin -59.0%
Adj. FCF Margin -94.6%
SBC / Revenue 125756.4%
SBC Impact (per share) -60.3%
Returns
Return on Assets -22.2%
Return on Equity -39.0%
Return on Invested Capital -33.0%
Return on Capital Employed -33.6%
Return on Tangible Assets -28.0%
Historical Growth (CAGR)
Revenue CAGR 3Y 70.9%
Revenue CAGR 5Y 72.3%
Revenue CAGR 10Y 2.2%
EPS CAGR 3Y 145.2%
EPS CAGR 5Y 57.9%
EPS CAGR 10Y 22.5%
FCF CAGR 3Y 73.2%
FCF CAGR 5Y 39.5%
FCF CAGR 10Y 0.7%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 9, 2025
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Cash Flow
Operating Cash Flow $-1.1M
Free Cash Flow $-1.1M
Adj. Free Cash Flow $-1.76M
FCF Per Share -$1.09
OCF Per Share -$1.09
OCF/S Ratio -327764.5%
Income Statement
Revenue $1.86M
Gross Profit $360K
Operating Income $-2.74M
EBITDA $-2.73M
Net Income $-2.2M
EPS (Diluted) -$3.64
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Add to Watchlist
Select watchlists to add or remove CYCCP